Aminasin 2.5% injection solution 10 ampl 2ml Chlorpromazine Аминазин Paranoid state

Aminasin Indications

Chronic paranoid and hallucinatory-paranoid state, the state of agitation in schizophrenia (hallucinatory-delusional, hebephrenic, catatonic syndromes), alcoholic psychosis, manic excitement in manic-depressive psychosis, mental disorders in epilepsy, agitated depression in patients with presenile psychosis, manic depressive psychosis, as well as other diseases, accompanied by excitation voltage.

Neurological diseases accompanied by increased muscle tone.

Meniere's disease, emesis, treatment and prevention of emesis in the treatment with anticancer agents and radiotherapy.
Itchy dermatitis.

In the combined therapy: Persistent pain, incl causalgia (in combination with analgesics), sleep disorders resistant nature (in combination with hypnotics and tranquilizers).

Dosage & Administration

The drug is administered intravenously and intramuscularly. The dose and regimen doctor determines individually depending on indications and the patient. In intramuscular highest single dose of 150 mg daily - 600 mg. Usually intramuscular injection should be administered 1-5 ml up to 3 times a day.

The course of treatment - a few months in high doses - up to 1.5 months, and then move to supporting treatment doses, gradually reducing the dose of 25-75 mg per day. In acute mental excitement injected intramuscularly 100-150 mg (4-6 ml) or intravenously 25-50 mg (1-2 ml chlorpromazine diluted in 20 ml of 5% or 40% glucose solution), if necessary 100mg (4 ml - 40 ml glucose). Enter slowly. When intravenously highest single dose - 100 mg daily - 250 mg.

In intramuscular and intravenous administration in children under 1 year of a single dose of 250-500 mg / kg body weight; children under 5 years old (weight 23 kg) - 40 mg per day, 5-12 years (weight - 23-46 kg) - 75 mg per day.

Debilitated patients and elderly patients administered 300 mg intramuscular or 150 mg per day - intravenously.

Contraindications

Increased individual sensitivity to chlorpromazine and other ingredients; severe liver and / or kidney, blood-forming organs, progressive system of the brain and spinal cord diseases,